News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,021 Results
Type
Article (65500)
Company Profile (418)
Press Release (684103)
Multimedia
Podcasts (94)
Webinars (13)
Section
Business (208692)
Career Advice (2952)
Deals (36809)
Drug Delivery (121)
Drug Development (85091)
Employer Resources (180)
FDA (17226)
Job Trends (16103)
News (358353)
Policy (35745)
Tag
Academia (2974)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (52949)
ALS (98)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (151)
Approvals (17192)
Artificial intelligence (292)
Autoimmune disease (28)
Automation (16)
Bankruptcy (377)
Best Places to Work (12433)
BIOSECURE Act (22)
Biosimilars (117)
Biotechnology (297)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (299)
Cancer (2417)
Cardiovascular disease (204)
Career advice (2485)
Career pathing (33)
CAR-T (172)
Cell therapy (470)
Cervical cancer (21)
Clinical research (68604)
Collaboration (910)
Company closure (1)
Compensation (540)
Complete response letters (30)
COVID-19 (2856)
CRISPR (47)
C-suite (263)
Cystic fibrosis (107)
Data (2264)
Decentralized trials (2)
Denatured (32)
Depression (55)
Diabetes (296)
Diagnostics (6830)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (132)
Drug pricing (123)
Drug shortages (30)
Duchenne muscular dystrophy (101)
Earnings (82673)
Editorial (45)
Employer branding (22)
Employer resources (157)
Events (115265)
Executive appointments (772)
FDA (18552)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (803)
Gene editing (117)
Generative AI (26)
Gene therapy (345)
GLP-1 (832)
Government (4947)
Grass and pollen (6)
Guidances (67)
Healthcare (20497)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (143)
Indications (30)
Infectious disease (3015)
Inflammatory bowel disease (150)
Inflation Reduction Act (10)
Influenza (56)
Intellectual property (101)
Interviews (533)
IPO (17208)
IRA (48)
Job creations (4140)
Job search strategy (2079)
Kidney cancer (11)
Labor market (34)
Layoffs (547)
Leadership (24)
Legal (8666)
Liver cancer (81)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (63)
Manufacturing (340)
MASH (74)
Medical device (14537)
Medtech (14542)
Mergers & acquisitions (20162)
Metabolic disorders (778)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2103)
NextGen: Class of 2025 (7356)
Non-profit (4995)
Now hiring (34)
Obesity (421)
Opinion (270)
Ovarian cancer (78)
Pain (99)
Pancreatic cancer (86)
Parkinson's disease (160)
Partnered (22)
Patents (250)
Patient recruitment (116)
Peanut (50)
People (60525)
Pharmaceutical (92)
Pharmacy benefit managers (20)
Phase I (21466)
Phase II (30165)
Phase III (22602)
Pipeline (1254)
Policy (165)
Postmarket research (2654)
Preclinical (9466)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (429)
Real estate (6514)
Recruiting (70)
Regulatory (24443)
Reports (41)
Research institute (2631)
Resumes & cover letters (472)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (141)
Series B (91)
Service/supplier (13)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (161)
Sponsored (34)
Startups (4026)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (44)
The Weekly (61)
Vaccines (810)
Venture capitalists (42)
Weight loss (297)
Women's health (36)
Worklife (20)
Date
Today (142)
Last 7 days (931)
Last 30 days (2782)
Last 365 days (34666)
2025 (11416)
2024 (37364)
2023 (42253)
2022 (53610)
2021 (58354)
2020 (57173)
2019 (50465)
2018 (38447)
2017 (35638)
2016 (35444)
2015 (41084)
2014 (33935)
2013 (29574)
2012 (31175)
2011 (31559)
2010 (29222)
Location
Africa (1012)
Alabama (60)
Alaska (7)
Arizona (204)
Arkansas (13)
Asia (45254)
Australia (7651)
California (6354)
Canada (2051)
China (558)
Colorado (279)
Connecticut (294)
Delaware (156)
Europe (101913)
Florida (937)
Georgia (219)
Hawaii (1)
Idaho (61)
Illinois (590)
India (29)
Indiana (323)
Iowa (10)
Japan (168)
Kansas (108)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (955)
Massachusetts (4831)
Michigan (235)
Minnesota (410)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (69)
New Jersey (1801)
New Mexico (31)
New York (1810)
North Carolina (1093)
North Dakota (9)
Northern California (2737)
Ohio (216)
Oklahoma (15)
Oregon (39)
Pennsylvania (1412)
Puerto Rico (12)
Rhode Island (35)
South America (1378)
South Carolina (24)
South Dakota (1)
Southern California (2371)
Tennessee (103)
Texas (939)
United States (24254)
Utah (187)
Virginia (163)
Washington D.C. (66)
Washington State (587)
West Virginia (3)
Wisconsin (66)
750,021 Results for "universite libre de bruxelles".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abbott Integrates Libre’s Data with Epic’s Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
April 30, 2025
·
4 min read
Press Releases
Abbott’s FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta
December 18, 2024
·
3 min read
Press Releases
Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual Health
March 28, 2025
·
3 min read
C-suite
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
Paul Stoffels left his perch as J&J’s chief scientific officer in 2022 to replace Galapagos’ founding CEO Onno van de Stolpe, inheriting a company that had suffered a series of clinical failures since its 1999 creation.
April 22, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Tr1X Announces Succession Plan: Appoints David de Vries CEO, Effective June 1; Bill Lis to Serve as Executive Chairman
March 31, 2025
·
3 min read
Press Releases
ERS Genomics and Université de Montréal Sign CRISPR/Cas9 License Agreement
October 1, 2024
·
2 min read
Press Releases
Care Access Announces Acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), a Leading Brazil-Based Clinical Research Center
March 10, 2025
·
3 min read
Press Releases
Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott’s FreeStyle Libre 3 Plus Sensor
October 30, 2024
·
2 min read
Press Releases
Breakthrough technology for human muscle fatigue measure, Myocene, gets FDA “de novo” approval.
January 30, 2025
·
2 min read
Deals
Servier Nabs Solid Tumor Asset in up to $780M Deal With Black Diamond
The French pharma is getting Black Diamond’s de-prioritized molecule for non-small cell lung cancers with specific mutations whose development had been paused to save money.
March 19, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 75,003
Next
